Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Endocrinol Metab. 2005 Jul;90(7):4063-7. Epub 2005 May 3.

Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.

Author information

1
karin.frankraue@raue-endokrinologie.de

Erratum in

  • J Clin Endocrinol Metab. 2005 Oct;90(10):5575.

Abstract

CONTEXT:

Primary hyperparathyroidism (HPT) presents as a part of inherited syndromes such as multiple endocrine neoplasia (MEN) types 1 and 2. In patients with MEN1, parathyroid hyperplasia or multiple adenomas occur in approximately 90-95%. MEN2A-related HPT is characterized by a mild hypercalcemia, which is mostly asymptomatic.

OBJECTIVE:

Here we present a family with coexistence of MEN1 gene mutation and RET mutation.

RESULTS:

Six family members carrying MEN1 gene mutation IVS5 + 1G>A only, one family member with RET mutation Y791F, and three family members with both MEN1 gene and RET mutation were studied. The key to diagnosis was recurrent HPT in a young male carrying RET mutation Y791F, a mutation not likely to give rise to recurrent HPT.

CONCLUSION:

MEN1 gene mutation and RET codon 791 mutation in the same patient did not affect the typical phenotype of MEN1 or MEN2, and also the course of diseases seems to be unchanged. The reason may be that both mutations, although contributing to tumor pathogenesis, do not interact and induce a worsening of the cancer syndromes.

PMID:
15870131
DOI:
10.1210/jc.2004-1759
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center